Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Branhamella catarrhalis as an indirect pathogen.

J K Wardle

    Drugs
    |January 1, 1986
    PubMed
    Summary

    Beta-lactamase-producing Branhamella catarrhalis protects other bacteria from penicillin antibiotics. This enzyme-producing bacteria may act as an indirect pathogen in bronchopulmonary infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ceftazidime in Gram-negative infections: three case reports.

    The Journal of antimicrobial chemotherapy·2009
    Same author

    An open study of the use of ceftazidime in Gram-negative infections.

    The Journal of antimicrobial chemotherapy·1983
    Same author

    Ventilation in operating rooms.

    British medical journal (Clinical research ed.)·1983
    Same author

    Listeria meningitis acquired by cross infection in a delivery suite.

    Lancet (London, England)·1981

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Penicillin antibiotics are standard treatments for bronchopulmonary infections.
    • Antibiotic resistance is a growing concern in treating bacterial infections.
    • Haemophilus influenzae and Streptococcus pneumoniae are common respiratory pathogens.

    Purpose of the Study:

    • To investigate the failure of penicillin antibiotics in specific bronchopulmonary infections.
    • To explore the role of Branhamella catarrhalis in treatment resistance.
    • To understand the mechanism of antibiotic inactivation in sputum.

    Main Methods:

    • Clinical observation of 7 patients with bronchopulmonary infections.
    • Sputum sample analysis for bacterial presence and antibiotic activity.
    • In vitro sensitivity testing of pathogens to penicillin antibiotics.

    Main Results:

    • Penicillin treatment failed to eradicate Haemophilus influenzae and Streptococcus pneumoniae in 7 patients.
    • These patients' sputum contained beta-lactamase-producing Branhamella catarrhalis.
    • No detectable antibacterial activity was found in sputum from patients receiving penicillin.

    Conclusions:

    • Branhamella catarrhalis may act as an indirect pathogen.
    • Beta-lactamase production by B. catarrhalis can protect other bacteria from penicillin.
    • This mechanism contributes to antibiotic treatment failure in complex respiratory infections.

    Related Experiment Videos